ALMS
ALUMIS INC.
Key Financials
Revenue
$24.1M
N/A
Net Income
$-243325000
↑ 17.3%
Operating Income
$-453804000
↓ 50.9%
Total Liabilities
$110.6M
↑ 36.8%
Total Assets
$411.9M
↑ 20.8%
Shareholders' Equity
$301.3M
↑ 15.8%
EPS (Diluted)
$-2.86
↑ 72.4%
Cash & Equivalents
$89.7M
↓ 47.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13D | 8/17/2026 | View on SEC |
| 10-Q | 8/13/2026 | View on SEC |
| 8-K | 8/13/2026 | View on SEC |
| 8-K | 8/10/2026 | View on SEC |
| SCHEDULE 13G | 8/6/2026 | View on SEC |
| 4 | 8/5/2026 | View on SEC |
| 4 | 8/5/2026 | View on SEC |
| 4 | 8/5/2026 | View on SEC |
| 4 | 8/5/2026 | View on SEC |
| 4 | 8/5/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ALMS |
| Company Name | ALUMIS INC. |
| CIK | 1847367 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 650-231-6625 |